Enliven Therapeutics Inc (ELVN) Directors and Executive Officers - CSIMarket
CSIMarket
 
Enliven Therapeutics Inc   (NASDAQ: ELVN)

Enliven Therapeutics Inc

Officers & Directors


Andrew Phillips
Director

Joseph P. Lyssikatos
Chief Scientific Officer and Director

Richard Heyman
Chairman of the Board of Directors

Jacob Bauer
Director

Rahul Ballal
Director

Samuel Kintz
President, Director, and Chief Executive Officer

Rishi Gupta
Director

Benjamin Hohl
Chief Financial Officer

Mika Derynck
Director,

Enliven Therapeutics Inc currently has 60 employees.






ELVN Management Effectiveness ELVN Revenue per Employee ELVN Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.